A Cincinnati Trasylol lawsuit may be the right choice for you if you have been injured by this dangerous drug. It was taken off the market in 2008 due to an increased risk of heart attack, stroke, and kidney failure. If you have been affected by this medication, you should contact a Cincinnati Trasylol lawsuit attorney for more information about your legal options. A Cincinnati Trasylol lawsuit attorney can help you file a claim and get the compensation you deserve.
Trasylol is used to prevent excessive bleeding during cardiac surgery
Bayer, the pharmaceutical company that manufactures Trasylol, has announced a temporary suspension of the drug for heart surgery patients. The suspension is in effect until the final results of the BART study are published, which is not likely to be until the end of 2008. Bayer and the FDA have agreed to phase the drug out of the market over time to prevent shortages and ensure that patients receive the best possible care. However, the German Federal Institute for Drugs and Medical Devices, which pushed for the immediate suspension of the drug, insisted that the drug be pulled from the market immediately. In Germany, there are now other, safer drugs available for use in cardiac surgery.
The study compared the two drugs, aprotinin, and clot-buster, in patients undergoing primary aortic valve repair or replacement. Patients taking Trasylol had a significantly lower risk of donor blood transfusion and fewer complications compared to those who did not receive clotting factor inhibitors. However, patients using both drugs still required transfusions.
It has been linked to kidney failure
Although there are some risks associated with this drug, the FDA has been conducting a review since early this year. Trasylol has been linked to increased risks of heart failure, kidney failure, and myocardial infarction, among other potential adverse effects. The drug is derived from bovine lung tissue and is used during heart surgery. Several other risks have also been reported, such as heart attack, stroke, and kidney failure.
Although it was originally approved for the treatment of hypertension, the drug has been linked to several serious health problems in recent weeks. Patients who received it before their heart surgery had an increased risk of kidney failure, heart problems, and other serious health issues. While it was initially prescribed to help patients limit their blood loss, the drug is now associated with a doubled risk of kidney failure. The drug has been recalled from the market in several countries, including the United States, Canada, Australia, and Europe.
Heart attacks
A heart attack and Trasylol lawsuit are being filed against Bayer AG, the maker of an anti-bleeding drug. The plaintiff, Samuel Nakis, died of kidney failure in 2005 following open-heart surgery. Despite having kidney disease, Nakis was prescribed Trasylol, also known as aprotinin. After taking the drug, Nakis developed kidney failure and underwent dialysis. Unfortunately, his life was cut short before he could fully recover from his condition.
The drug was withdrawn from the U.S. market in 2008 after it was linked to an increased risk of heart attacks, stroke, and kidney failure. If you have suffered from one of these complications, it is essential to speak with a Cincinnati Trasylol attorney. The attorneys at Saiontz & Kirk, P.A. are prepared to help you pursue compensation for your losses.
Strokes
In a recent study, Bayer failed to disclose to the Federal Drug Administration that Trasylol was linked to an increased risk of stroke and heart attack. This could have caused a stroke, which is a potentially fatal condition. This drug is also linked to kidney failure and unexpected death after surgery. Although the FDA found the drug to be safe for some people, a large majority of patients who were taking it suffered serious side effects.
In November 2007, Bayer AG, the manufacturer of Trasylol, suspended the drug’s sale in the United States. The drug was a common clotting agent used to prevent bleeding during heart surgery. Because of the risks associated with this drug, the FDA requested its withdrawal from the market. Thousands of patients have already filed lawsuits against Bayer, and the company is responsible for the recall.
Death
The Bayer Corp., which manufactures Trasylol, recently settled a wrongful death lawsuit with the plaintiffs in a case. The U.S. District Court for the Southern District of Florida dismissed the plaintiffs’ expert testimony as unreliable and granted summary judgment to Bayer. The woman who died of an adverse reaction to Trasylol received the prescription drug to prevent bleeding during a mitral valve replacement surgery in 2006. Charlotte Harper, the attorney representing her estate, said the drug caused kidney failure and heart failure and caused her death. The lawsuit was part of federal multidistrict litigation filed in the Southern District of Florida.
While Dr. Blond testified that Trasylol administration increased Mr. Miller’s risk of death, his opinion is irrelevant to the case. Although his opinion may be true, it is irrelevant in this context. Because a doctor cannot testify that Trasylol is a significant contributor to the injury of the plaintiff, it cannot establish that the drug posed a substantial risk to his early death. Thus, Dr. Blond’s testimony is excluded without discussion.